Trial Profile
Results From a 24 Week, Double-blind, Placebo-controlled Trial of EMDR Combined With Venlafaxine XR in the Treatment of Posttraumatic Stress Disorder
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Acronyms EMDRVEN
- 29 Jan 2016 Status changed from not yet recruiting to discontinued.
- 07 May 2015 New trial record